Transgenomic Q1 Revenues Grow 4 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Transgenomic said after the close of the market Thursday that its first quarter revenues increased 4 percent year over year, buoyed by a spike in laboratory services sales.

The company also said that it plans to launch its first services and products based on its flagship multiplex ICE-COLD PCR (MX-ICP) technology in June.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.